İ. C. HAZNEDAROĞLU, "Monitoring the Response to Tyrosine Kinase Inhibitor (TKI) Treatment in Chronic Myeloid Leukemia (CML)," MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES , vol.6, no.1, 2014
HAZNEDAROĞLU, İ. C. 2014. Monitoring the Response to Tyrosine Kinase Inhibitor (TKI) Treatment in Chronic Myeloid Leukemia (CML). MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES , vol.6, no.1 .
HAZNEDAROĞLU, İ. C., (2014). Monitoring the Response to Tyrosine Kinase Inhibitor (TKI) Treatment in Chronic Myeloid Leukemia (CML). MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES , vol.6, no.1.
HAZNEDAROĞLU, İBRAHİM. "Monitoring the Response to Tyrosine Kinase Inhibitor (TKI) Treatment in Chronic Myeloid Leukemia (CML)," MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES , vol.6, no.1, 2014
HAZNEDAROĞLU, İBRAHİM C. . "Monitoring the Response to Tyrosine Kinase Inhibitor (TKI) Treatment in Chronic Myeloid Leukemia (CML)." MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES , vol.6, no.1, 2014
HAZNEDAROĞLU, İ. C. (2014) . "Monitoring the Response to Tyrosine Kinase Inhibitor (TKI) Treatment in Chronic Myeloid Leukemia (CML)." MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES , vol.6, no.1.
@article{article, author={İBRAHİM CELALETTİN HAZNEDAROĞLU}, title={Monitoring the Response to Tyrosine Kinase Inhibitor (TKI) Treatment in Chronic Myeloid Leukemia (CML)}, journal={MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES}, year=2014}